|
|
|
Insider
Information: |
Vaishnaw Akshay |
Relationship: |
President |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
22,774 |
|
Indirect Shares
|
515 |
|
|
Direct
Value |
$3,773,652 |
|
|
Indirect Value
|
$85,336 |
|
|
Total
Shares |
23,289 |
|
|
Total
Value |
$3,858,987 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
2
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
Percentage
Gain/Loss : |
0.0%
|
-26.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
![](../../../Gifs/iconPlus.jpg) |
Alnylam Pharmaceuticals Inc |
ALNY |
President |
2023-08-04 |
22,774 |
2023-08-04 |
515 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
96 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALNY |
Alnylam Pharmaceuticals I... |
EVP, R&D |
|
2016-12-30 |
4 |
D |
$37.44 |
$187,200 |
D/D |
(5,000) |
10,297 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
|
2020-02-07 |
4 |
OE |
$42.22 |
$960,505 |
D/D |
22,750 |
34,923 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
|
2020-04-20 |
4 |
OE |
$42.22 |
$927,616 |
D/D |
21,971 |
36,090 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
|
2020-06-22 |
4 |
OE |
$42.22 |
$40,953 |
D/D |
970 |
15,089 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
|
2020-09-29 |
4 |
OE |
$42.22 |
$40,996 |
D/D |
971 |
15,090 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
|
2021-06-18 |
4 |
OE |
$42.22 |
$723,495 |
D/D |
11,804 |
25,923 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President |
|
2022-12-05 |
4 |
OE |
$42.22 |
$299,938 |
D/D |
5,079 |
23,425 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, R&D, CMO |
|
2016-11-30 |
4 |
AS |
$44.34 |
$1,311,998 |
D/D |
(29,165) |
5,750 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
|
2013-09-10 |
4 |
AS |
$57.39 |
$359,238 |
D/D |
(6,250) |
12,588 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
|
2013-12-16 |
4 |
AS |
$60.19 |
$905,298 |
D/D |
(15,000) |
12,588 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
|
2013-12-17 |
4 |
AS |
$60.59 |
$1,127,761 |
D/D |
(18,480) |
12,588 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
|
2021-08-09 |
4 |
OE |
$63.00 |
$682,542 |
D/D |
10,834 |
22,049 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President |
|
2023-02-10 |
4 |
OE |
$63.00 |
$1,947,519 |
D/D |
30,913 |
53,014 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
SVP, R&D |
|
2017-05-15 |
4 |
AS |
$65.00 |
$2,843,750 |
D/D |
(43,750) |
10,297 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
|
2014-06-17 |
4 |
AS |
$69.33 |
$741,798 |
D/D |
(10,625) |
0 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
|
2014-09-16 |
4 |
AS |
$71.34 |
$765,463 |
D/D |
(10,625) |
0 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
|
2014-03-18 |
4 |
AS |
$73.34 |
$2,423,223 |
D/D |
(32,769) |
0 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, R&D |
|
2017-06-13 |
4 |
D |
$74.31 |
$31,953 |
D/D |
(430) |
11,535 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, R&D |
|
2017-05-23 |
4 |
AS |
$75.00 |
$825,000 |
D/D |
(11,000) |
10,297 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
|
2014-01-24 |
4 |
AS |
$84.57 |
$676,589 |
D/D |
(7,890) |
0 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
|
2014-01-23 |
4 |
D |
$89.49 |
$420,424 |
D/D |
(4,698) |
7,890 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
|
2014-02-21 |
4 |
D |
$90.10 |
$235,611 |
I/I |
(2,615) |
0 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
|
2018-08-13 |
4 |
D |
$90.95 |
$69,668 |
D/D |
(766) |
12,173 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
|
2014-12-16 |
4 |
AS |
$91.47 |
$994,588 |
D/D |
(10,626) |
0 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
|
2020-04-07 |
4 |
D |
$104.75 |
$263,410 |
D/D |
(2,513) |
14,119 |
0 |
- |
|
96 Records found
|
|
Page 3 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|